Editorial: leukocyte-targeting toxins as therapeutics in allergic asthma.

J Leukoc Biol

Department of Biomedical and Molecular Sciences, Queen's University, Kingston, Ontario, Canada

Published: March 2015

AI Article Synopsis

  • Leukotoxin A is being explored as a potential target for treatment in allergic asthma by blocking the recruitment of inflammatory white blood cells (leukocytes).
  • This approach aims to reduce the inflammation and symptoms associated with allergic asthma, potentially leading to better management of the condition.
  • Current research focuses on understanding how leukotoxin A interacts with the immune system and its effectiveness in controlling asthma-related inflammation.

Article Abstract

Discussion on leukotoxin A as a potential therapeutic target to halt the recruitment of inflammatory leukocytes in allergic asthma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477893PMC
http://dx.doi.org/10.1189/jlb.3CE1014-462RDOI Listing

Publication Analysis

Top Keywords

allergic asthma
8
editorial leukocyte-targeting
4
leukocyte-targeting toxins
4
toxins therapeutics
4
therapeutics allergic
4
asthma discussion
4
discussion leukotoxin
4
leukotoxin potential
4
potential therapeutic
4
therapeutic target
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!